Early aspirin discontinuation linked to benefits in low-risk patients with myocardial infarction undergoing coronary stenting


Notes to editor

This press release accompanies a presentation at ESC Congress 2025.  

It does not necessarily reflect the opinion of the European Society of Cardiology.  

 

ESC Press Office
Tel: +33 6 61 40 18 84   
Email: press@escardio.org

Follow European Society of Cardiology News on LinkedIn

 

Funding: This study was funded by MicroPort CRM. 

Disclosures: Professor Tarantini reports receiving lecture fees from MicroPort CRM. 

 

References and notes: 

1‘TARGET-FIRST: Early aspirin discontinuation after PCI in acute MI patients’ presented during HOT LINE 7 on 31 August 2025 at 16:45 to 16:55 in Madrid (Main Auditorium) and simultaneously published in New England Journal of Medicine. 

2Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720−3826. 

 

About ESC Congress 2025 

It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in Madrid and online – from 29 August to 1 September 2025. Explore the scientific programme. More information is available from the ESC Press Office at press@escardio.org. 

About the European Society of Cardiology

The ESC brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.


Continue Reading